enVVeno Medical (NVNO) Cash from Operations (2017 - 2026)

enVVeno Medical's Cash from Operations history runs 10 years deep, the most recent figure standing at 3238000.0 for Q1 2026.

• On a quarterly basis, Cash from Operations rose 19.41% year-over-year to 3238000.0 in Q1 2026; TTM through Mar 2026 was 14788000.0, a 14.55% increase from a year earlier, with the FY2025 full-year figure at 15568000.0, up 7.54% from the prior year.
• Cash from Operations grew to 3238000.0 in Q1 2026 per NVNO's latest filing, from 3443000.0 in the prior quarter.
• Across five years, Cash from Operations topped out at 3238000.0 in Q1 2026 and bottomed at 5109000.0 in Q1 2023.
• The 5-year median for Cash from Operations is 4018000.0 (2025), against an average of 4124764.71.
• Across the five-year window, Cash from Operations tumbled 100.76% in 2022 and jumped 32.56% in 2025, its largest moves.
• Year by year, Cash from Operations stood at 3856000.0 in 2022, then dropped by 28.97% to 4973000.0 in 2023, then dropped by 2.65% to 5105000.0 in 2024, then soared by 32.56% to 3443000.0 in 2025, then climbed by 5.95% to 3238000.0 in 2026.
• Per Business Quant, the three latest NVNO Cash from Operations figures stand at 3238000.0 (Q1 2026), 3443000.0 (Q4 2025), and 4392000.0 (Q3 2025).